Geron Announces Conference Call to Discuss First Quarter 2014 Financial Results


Menlo Park, Calif., April 23, 2014 - Geron Corporation (GERN) will announce its financial results for the first quarter ended March 31, 2014, on Thursday, May 1, 2014, after the market close. Geron`s management will also host a conference call for analysts and investors on Thursday, May 1, 2014, at 4:30 p.m. Eastern Time to discuss the company`s first quarter results and recent events.

Participants can access the conference call live via telephone by dialing 866-578-5771 (U.S.); 617-213-8055 (international). The passcode is 69839849. If accessing the conference call by telephone, please dial in at least 10 minutes early to minimize any delay in joining the call. A live audio-only webcast is also available at The audio webcast of the conference call will be available for replay approximately one hour following the live broadcast through June 1, 2014.

About Geron

Geron is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit


Anna Krassowska, Ph.D.
Investor and Media Relations


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Geron Corp. via GlobeNewswire

View Comments (0)